- Home
- WAFDP vs GALT Comparison
WAFDP vs GALT Comparison
Compare WAFDP & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFDP
- GALT
- Stock Information
- Founded
- WAFDP N/A
- GALT 2000
- Country
- WAFDP United States
- GALT United States
- Employees
- WAFDP 2208
- GALT N/A
- Industry
- WAFDP Major Banks
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- WAFDP Finance
- GALT Health Care
- Exchange
- WAFDP Nasdaq
- GALT Nasdaq
- Market Cap
- WAFDP N/A
- GALT 83.5M
- IPO Year
- WAFDP N/A
- GALT N/A
- Fundamental
- Price
- WAFDP $16.05
- GALT $2.52
- Analyst Decision
- WAFDP
- GALT Buy
- Analyst Count
- WAFDP 0
- GALT 2
- Target Price
- WAFDP N/A
- GALT $6.00
- AVG Volume (30 Days)
- WAFDP N/A
- GALT 1.5M
- Earning Date
- WAFDP N/A
- GALT 08-12-2025
- Dividend Yield
- WAFDP N/A
- GALT N/A
- EPS Growth
- WAFDP N/A
- GALT N/A
- EPS
- WAFDP N/A
- GALT N/A
- Revenue
- WAFDP N/A
- GALT N/A
- Revenue This Year
- WAFDP N/A
- GALT N/A
- Revenue Next Year
- WAFDP N/A
- GALT N/A
- P/E Ratio
- WAFDP N/A
- GALT N/A
- Revenue Growth
- WAFDP N/A
- GALT N/A
- 52 Week Low
- WAFDP N/A
- GALT $0.73
- 52 Week High
- WAFDP N/A
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- WAFDP 57.24
- GALT 63.30
- Support Level
- WAFDP $15.55
- GALT $2.07
- Resistance Level
- WAFDP $16.25
- GALT $2.36
- Average True Range (ATR)
- WAFDP 0.20
- GALT 0.27
- MACD
- WAFDP 0.06
- GALT -0.01
- Stochastic Oscillator
- WAFDP 77.78
- GALT 61.64
About WAFDP WaFd Inc. Depositary Shares
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.